Rocket Lab (NASDAQ:RKLB) Issues Earnings Results

Key Points

• Rocket Lab reported a record FY2025 revenue of $602M (up 38% YoY) and a Q4 record of ~$180M with record gross margins, and its backlog grew to $1.85B, helped by an $816M SDA Tranche 3 award.
• The Neutron program hit a setback when a Stage 1 tank ruptured during qualification, prompting a manufacturing change and pushing the targeted first launch to Q4 2026, while the company posted an EPS miss (‑$0.09 vs. consensus ‑$0.05) and warned of continued negative free cash flow and elevated R&D/capex.

Rocket Lab (NASDAQ:RKLB - Get Free Report) announced its quarterly earnings results on Thursday. The rocket manufacturer reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.04), FiscalAI reports. The firm had revenue of $179.65 million for the quarter, compared to analyst estimates of $178.18 million. Rocket Lab had a negative return on equity of 27.26% and a negative net margin of 35.64%.The business's revenue was up 35.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.10) earnings per share.

Here are the key takeaways from Rocket Lab's conference call:

• Rocket Lab reported a record year with $602M revenue in 2025 (up 38% YoY), a Q4 record of $180M, record gross margins (Q4 GAAP 38%, non‑GAAP 44%), and a backlog of $1.85B, demonstrating strong top‑line growth and margin expansion.
• The company won the largest contract in its history—an $816M SDA Tranche 3 Tracking Layer award (bringing SDA awards to >$1.3B) and sees additional subsystem capture opportunities, with recent acquisitions like Geost cited as instrumental in securing the work.
• Neutron development hit a setback when a Stage 1 tank ruptured during qualification due to a manufacturing defect in a hand‑laid part; production has shifted to an AFP process and launch timing was moved to a targeted Q4 2026, with R&D and testing intensity (and associated costs) elevated as a result.
• Operational execution remained strong—Rocket Lab launched a company‑record 21 missions in 2025 (seven in Q4), expanded HASTE hypersonic testing, and added 30+ new launches to the manifest, including multi‑launch deals such as BlackSky and national security customers.
• Liquidity sits near $1.1B (including $280.6M from ATM sales) and the company guided Q1 2026 revenue to $185–$200M, but warned of continued negative free cash flow and elevated capex driven by Neutron and SDA program investments.

Rocket Lab Stock Up 3.5%

Shares of Rocket Lab stock traded up $2.45 during trading hours on Thursday, hitting $72.65. 18,144,465 shares of the company's stock traded hands, compared to its average volume of 16,382,059. Rocket Lab has a twelve month low of $14.71 and a twelve month high of $99.58. The company has a market cap of $38.81 billion, a PE ratio of -191.18 and a beta of 2.16. The company has a quick ratio of 2.83, a current ratio of 3.18 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $78.14 and a 200-day simple moving average of $60.83.

Rocket Lab News Roundup

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Reported record results: Rocket Lab posted record Q4 revenue (~$180M) and a record FY2025 revenue of $602M, and said backlog grew ~73% year‑over‑year to $1.85B — data that supports future revenue visibility and likely underpins the rally. Read More.
• Positive Sentiment: Strong commercial wins: secured a multi‑launch contract with BlackSky for four dedicated Electron missions, reinforcing launch demand and recurring revenue opportunity. Read More.
• Positive Sentiment: Expanded in‑house capabilities via M&A and facilities: completed acquisition of Optical Support, Inc. (optics) and acquired Precision Components Ltd to add precision machining capacity — both strengthen vertical integration and supply‑chain control for spacecraft/payload programs. Read More. Read More.
• Positive Sentiment: New product roadmap: introduced advanced silicon solar arrays (targeting space‑based data centers) and highlighted CHIPS Act support — positions Rocket Lab in growing space power/constellation markets and diversifies revenue streams. Read More.
• Neutral Sentiment: Guidance mixed: management guided Q1 revenue to $185–$200M (strong absolute growth), but some market commentary parsed the cadence/guidance as less bullish versus elevated expectations — a near‑term driver of volatility. Read More.
• Negative Sentiment: EPS miss and continuing losses: reported GAAP loss of $0.09 vs. consensus ~($0.05); negative margins and ROE highlight that growth is not yet translating to profitability and may cap multiple expansion. Read More.
• Negative Sentiment: Neutron timing risk and other execution concerns: the Neutron medium‑lift vehicle’s first launch has slipped to late‑2026, and program timing remains a headline risk that can pressure the stock if further delays occur. Read More.
• Negative Sentiment: Insider selling and valuation scrutiny: disclosures and third‑party data show significant insider sales and a premium valuation that keep some investors cautious despite growth. Read More.

Insider Transactions at Rocket Lab

In other Rocket Lab news, Director Nina Armagno sold 27,314 shares of the firm's stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $68.21, for a total transaction of $1,863,087.94. Following the completion of the sale, the director owned 108,940 shares in the company, valued at $7,430,797.40. This trade represents a 20.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Merline Saintil sold 96,000 shares of Rocket Lab stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $86.58, for a total value of $8,311,680.00. Following the sale, the director owned 292,529 shares in the company, valued at $25,327,160.82. This represents a 24.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,138,979 shares of company stock valued at $265,048,346 in the last three months. 11.90% of the stock is currently owned by company insiders.

Institutional Trading of Rocket Lab

Institutional investors have recently added to or reduced their stakes in the stock. Mcguire Capital Advisors Inc. acquired a new position in Rocket Lab during the 4th quarter worth $27,000. Compound Planning Inc. lifted its position in shares of Rocket Lab by 18.7% during the fourth quarter. Compound Planning Inc. now owns 5,432 shares of the rocket manufacturer's stock worth $379,000 after purchasing an additional 855 shares during the last quarter. Axxcess Wealth Management LLC acquired a new position in Rocket Lab in the fourth quarter worth about $200,000. Corient Private Wealth LLC increased its holdings in Rocket Lab by 5.2% in the fourth quarter. Corient Private Wealth LLC now owns 234,053 shares of the rocket manufacturer's stock valued at $16,319,000 after buying an additional 11,557 shares during the last quarter. Finally, Ameriflex Group Inc. acquired a new stake in Rocket Lab during the fourth quarter valued at approximately $38,000. 71.78% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

RKLB has been the topic of several research reports. Citigroup restated a "market perform" rating on shares of Rocket Lab in a report on Wednesday, November 12th. Cantor Fitzgerald reissued an "overweight" rating on shares of Rocket Lab in a research report on Wednesday, December 3rd. Wall Street Zen raised shares of Rocket Lab from a "sell" rating to a "hold" rating in a research note on Sunday, February 8th. The Goldman Sachs Group upped their price target on shares of Rocket Lab from $47.00 to $69.00 and gave the stock a "neutral" rating in a research report on Tuesday, January 20th. Finally, Zacks Research lowered Rocket Lab from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Rocket Lab presently has a consensus rating of "Moderate Buy" and an average target price of $72.92.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.